To study the management of ashwatha ghanavati in vatarakta (gout)

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASHWATHA GHANAVATI IN THE MANEGMENT OF VATARAKTA (GOUT) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068246

Enrollment

Registered

2024-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical symptoms of vatarakta like pain in joint,swelling,burning sensation,tenderness at joints , stiffness,local colour changes Sr uric acid level 3-12mg/dl

Exclusion criteria

Exclusion criteria: Patients with severe form of other systemic disorder like cardiac disease ,renal failure ,CAV will be excluded. Pregnant women and lactating mother Injury requiring surgical interventions Any condition interfering the course of treatment were excluded Secondary hyperuricemia due to leukemia ,lypoma,polycythemia

Design outcomes

Primary

Measure	Time frame
reduction in symptoms: intense pain, swelling, stifness, and decrease in serum uric acid of pts.Timepoint: 30 days study with follw up on 15th and 30th day	—

Secondary

Measure	Time frame
To obeserve any adverse effect if anyTimepoint: 30 days study follw uo on 15th, 30th day	—

Countries

India

Contacts

Public ContactDr Digambar G Dipankar

Dr.D.Y.Patil College Of Ayurveda And Research Center Pimpri Pune

digambar.dipankar@dpu.edu.in9822279321

Outcome results